Science ❯ Medical Research

Oncology

Tumor Biology Cancer Treatment Immunotherapy Clinical Trials Treatment Innovations Epidemiology Hematology Diagnostic Techniques Cancer Types Gastroenterology Bladder Cancer Research Cancer Treatments Patient Education Treatment Advances Clinical Studies Therapeutic Vaccines Immunotherapy Research Voice Disorders Collaboration Melanoma Hair Follicle Biology Solid Tumors Cancer Biology Gene Therapy Precision Medicine Viral Infections Blood Cancer Pancreatic Cancer Therapies Genetic Abnormalities Early Detection Techniques Cancer Screening Cancer Detection Therapeutics Therapeutic Development Diagnostic Methods Computational Oncology Patient Outcomes Tumor Microenvironment Innovative Treatments Preventive Health Radiation Therapy Hormonal Therapy Pediatric Oncology Cancer Prevention Genetic Testing Antibody Therapy Drug Development Biologics Bowel Cancer Studies Trial Phases Institutional Governance Chondrosarcoma Lung Cancer Treatments Surgery mRNA Technology Prostate Cancer Digestive Cancers Rare Tumors Brain Cancer

Zymeworks and BeOne Say Phase 3 Zanidatamab Regimens Top Two Years’ Survival in First-Line HER2+ GEA

Full results will be presented as a late-breaking ASCO GI talk on Jan. 8 ahead of anticipated regulatory evaluation.

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Zymeworks Shifts to Royalty Model After Ziihera’s Phase 3 Win in HER2‑Positive Gastroesophageal Cancer

Viral Clip of Putin’s Hands Revives Health Questions

Lung Cancer Survival Climbs With Earlier Detection as ALA Flags Threats to Progress

Florida Awards $30 Million to Four Children’s Hospitals for Pediatric Cancer Research and Care

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Serial Biopsies Reveal Responses Missed by MRI in Glioblastoma CAN-3110 Trial

Lobular Breast Cancer Is Rising Fast, Now Over 1 in 10 U.S. Cases

Glioblastoma Erodes the Skull and Alters Immune Marrow, Raising Treatment Cautions

AACR’s 2025 Report Shows Cancer Survival Gains as Early-Onset Cases Climb, Presses for Sustained U.S. Funding

Science Advances Study Identifies Pentose Phosphate Pathway Vulnerability in MPNST

Respiratory Viruses Can Awaken Dormant Cancer Cells via IL-6-Driven Inflammation